Table 1 Baseline characteristics of the enrolled 11 clinical cohort studies
First author | Year | Country | Sample Size | Gender (M/F) | Age (years) | Method | |||
|---|---|---|---|---|---|---|---|---|---|
LAG | OG | LAG | OG | LAG | OG | ||||
Choi YB [17] | 2002 | Japan | 10 | 10 | 7/3 | 9/1 | 58.7 (33 ~ 80) | 60.4 (25 ~ 78) | ELISA |
Hayashi H [18] | 2005 | Japan | 14 | 14 | 9/5 | 13/1 | 56 (47 ~ 70) | 62 (49 ~ 75) | ELISA |
Jung IK [34] | 2008 | Korea | 10 | 10 | 4/6 | 9/1 | 54.8 ± 16.1 | 62.9 ± 6.6 | ELISA |
Shao WX [30] | 2009 | China | 47 | 47 | 31/16 | 30/17 | 57.7 (26 ~ 77) | 57.0 (28 ~ 76) | ELISA |
Chen XZ [5] | 2011 | China | 15 | 15 | 12/3 | 12/3 | 52.3 ± 12.2 | 54.3 ± 12.3 | ELISA |
Park JY [35] | 2012 | Korea | 120 | 30 | 65/55 | 18/12 | 55 (45 ~ 64) | 50 (45 ~ 54) | ELISA |
Huang X [29] | 2012 | China | 30 | 30 | 21/9 | 23/7 | 56 | 58 | ELISA |
Zhou B [33] | 2012 | China | 45 | 45 | 24/21 | 25/20 | 51.8 ± 10.6 | 50.1 ± 11.4 | ELISA |
Chen Z [28] | 2013 | China | 36 | 36 | 19/17 | 21/15 | 52.6 ± 4.2 | 53.2 ± 4.8 | ELISA |
Xia YB [31] | 2013 | China | 55 | 59 | 33/22 | 39/20 | 54.0 ± 3.2 | 52.7 ± 1.8 | ELISA |
Yin ZW [32] | 2014 | China | 45 | 44 | 29/16 | 33/11 | 55.9 ± 8.5 | 56.1 ± 7.9 | ELISA |